Risk Factors for Incident Diabetes in a Cohort Taking First-Line Nonnucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy

S. Karamchand, R. Leisegang, M. Schomaker, G. Maartens, L. Walters, M. Hislop, J. A. Dave, N. S. Levitt, K. Cohen
March 2016
PDF Project
Type
Journal article
Publication
Medicine, 95(9): pp.e2844
diabetes model selection imputation

Related